Velsipity ,


Ulcerative colitis ,
Drug Class
Targeted Synthetic Small Molecules
Delivery Method
Oral or
Brand name:
Velsipity ,
Drug name:
Drug type
S1P Receptor Modulator
Recommendations for pregnancy

Do not use Velsipity if you are pregnant or plan to become pregnant. May cause fetal harm. Use effective contraception during treatment and for one week after stopping Velsipity.

Recommendations for breastfeeding

It is unknown if Velsipity passes into breast milk. Talk to your doctor about the best way to feed your baby if you take Velsipity.

Most common side effects

Common side effects may include: upper respiratory tract infections, elevated liver enzymes, headache, and dizziness.


Do not take Velsipity if in the last 6 months you experienced myocardial infarction, unstable angina pectoris, stroke, transient ischemic attack, decompensated heart failure requiring hospitalization, or Class III or IV heart failure or have or have had a history of unusual heartbeats (arrhythmia) that is not corrected by a pacemaker. For more information on Velsipity please view the FDA label insert.

Learn more about Targeted Synthetic Small Molecules

YouTube Video (diZ-9aBqgwc)

Video Length 00:01:11

YouTube Video (diZ-9aBqgwc)